These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2594106)

  • 41. [Dialysis versus renal transplantation; a comparative study on medical cost and quality of life in patients with chronic renal failure].
    Tajima A; Ueda D; Hirai M; Morinaga S; Sudoko H; Yamaguchi Y; Mitsuhashi T; Nakano M; Kanbayashi T; Ushiyama T
    Hinyokika Kiyo; 1987 Oct; 33(10):1536-41. PubMed ID: 3128069
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Should the medicare ESRD program pay for daily dialysis? An ethical analysis.
    Anantharaman P; Moss AH
    Adv Chronic Kidney Dis; 2007 Jul; 14(3):290-6. PubMed ID: 17603984
    [TBL] [Abstract][Full Text] [Related]  

  • 43. How hospitals can adapt to managing ESRD patient care.
    Scheel PJ; Thompson M
    Nephrol News Issues; 1998 May; 12(5 Suppl):9-10. PubMed ID: 9652291
    [No Abstract]   [Full Text] [Related]  

  • 44. EPO--one year later. Part II. Balancing the costs and benefits.
    Blagg C
    Nephrol News Issues; 1990 Jun; 4(6):22, 38. PubMed ID: 2119485
    [No Abstract]   [Full Text] [Related]  

  • 45. Conditions for coverage fail to relieve administrative burden.
    Wish D
    Nephrol News Issues; 2005 Sep; 19(10):46-7, 51. PubMed ID: 16187648
    [No Abstract]   [Full Text] [Related]  

  • 46. HCFA, Stark eye Medicare ESRD expenditures.
    Koska MT
    Hospitals; 1988 May; 62(10):84. PubMed ID: 3283025
    [No Abstract]   [Full Text] [Related]  

  • 47. Variations in living donor graft rates by dialysis clinic: effect on outcome and cost of chronic renal failure therapy.
    Baltzan MA; Ahmed S; Baltzan RB; Marshall RP; Thoma EL; Nicol MF
    Clin Nephrol; 1997 Jun; 47(6):351-5. PubMed ID: 9202863
    [TBL] [Abstract][Full Text] [Related]  

  • 48. KI study: older patients with CKD are costly as they transition to dialysis.
    St Peter W
    Nephrol News Issues; 2004 Oct; 18(11):85. PubMed ID: 15551617
    [No Abstract]   [Full Text] [Related]  

  • 49. The cost of hemodialysis in Iran.
    Arefzadeh A; Lessanpezeshki M; Seifi S
    Saudi J Kidney Dis Transpl; 2009 Mar; 20(2):307-11. PubMed ID: 19237828
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Angio and peritoneal access for endstage renal disease in the community hospital: a cost analysis.
    Chapman JE; Sinicrope RA; Clark DM
    Am Surg; 1986 Jun; 52(6):315-9. PubMed ID: 3717777
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Cost-effectiveness analysis of treatment for end-stage renal disease].
    Asgeirsdóttir TL; Asmundsdóttir G; Heimisdóttir M; Jónsson E; Pálsson R
    Laeknabladid; 2009 Nov; 95(11):747-53. PubMed ID: 19996463
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A simulation model to estimate the cost and effectiveness of alternative dialysis initiation strategies.
    Lee CP; Chertow GM; Zenios SA
    Med Decis Making; 2006; 26(5):535-49. PubMed ID: 16997929
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Transplantation and the end-stage renal disease program.
    Heitman J
    Pharos Alpha Omega Alpha Honor Med Soc; 1993; 56(1):2-8. PubMed ID: 8434036
    [No Abstract]   [Full Text] [Related]  

  • 54. Surviving change: Can the ESRD provisions in the SCHIP create a level playing field?
    Gardner AV
    Nephrol News Issues; 2007 Sep; 21(10):52-3. PubMed ID: 17918480
    [No Abstract]   [Full Text] [Related]  

  • 55. Management of end stage renal disease (ESRD) -- the debate continues.
    Feng PH
    Singapore Med J; 1982 Feb; 23(1):1-2. PubMed ID: 7112134
    [No Abstract]   [Full Text] [Related]  

  • 56. Competing in the ESRD marketplace.
    Nephrol News Issues; 1998 May; 12(5 Suppl):11, 15-6. PubMed ID: 9652292
    [No Abstract]   [Full Text] [Related]  

  • 57. Dialysis strategy: cost and effectiveness.
    Kerr DN
    Proc Eur Dial Transplant Assoc; 1981; 18():664-73. PubMed ID: 6799954
    [No Abstract]   [Full Text] [Related]  

  • 58. The costs of renal services in Britain.
    Mallick NP
    Nephrol Dial Transplant; 1997; 12 Suppl 1():25-8. PubMed ID: 9075225
    [No Abstract]   [Full Text] [Related]  

  • 59. Establishing and controlling chronic renal failure treatment costs. A pressing need.
    Martín Hernández R
    Nefrologia; 2011; 31(3):256-9. PubMed ID: 21629334
    [No Abstract]   [Full Text] [Related]  

  • 60. Treatment of renal failure in the light of increasingly limited resources.
    Wing AJ
    Contrib Nephrol; 1985; 44():260-74. PubMed ID: 3987290
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.